Radiofrequency ablation of benign non-functioning thyroid nodules: 4-year follow-up results for 111 patients.

Lim, Hyun Kyung; Lee, Jeong Hyun; Ha, Eun Ju; Sung, Jin Young; Kim, Jae Kyun; Baek, Jung Hwan
European radiology
2013Apr ; 23 ( 4 ) :1044-9.
ÀúÀÚ »ó¼¼Á¤º¸
Lim, Hyun Kyung -
Lee, Jeong Hyun -
Ha, Eun Ju -
Sung, Jin Young -
Kim, Jae Kyun -
Baek, Jung Hwan -
ABSTRACT
OBJECTIVES: To evaluate the clinical outcomes and safety of radiofrequency (RF) ablation for benign non-functioning thyroid nodules over a 4-year follow-up.

METHODS: We evaluated 126 benign non-functioning thyroid nodules of 111 patients treated with RF ablation and followed-up more than 3 years. RF ablation was performed using the Cool-Tip RF system and an internally cooled electrode. Nodule volume and cosmetic and symptom scores were evaluated before treatment and during follow-up. Complications and factors related to efficacy were evaluated.

RESULTS: The mean follow-up duration was 49.4?±?13.6 months. Thyroid nodule volume decreased significantly, from 9.8?±?8.5 ml before ablation to 0.9?±?3.3 ml (P?
CONCLUSIONS: RF ablation was effective in shrinking benign thyroid nodules and in controlling nodule-related problems over a 4-year follow-up. There were no life-threatening complications or sequelae. Therefore, RF ablation can be used as a non-surgical treatment for patients with benign non-functioning thyroid nodules.
na
MESH
Adult, Aged, Catheter Ablation/*statistics & numerical data, Female, Follow-Up Studies, Humans, Male, Middle Aged, Prevalence, Republic of Korea/epidemiology, Risk Factors, Thyroid Nodule/*epidemiology/*surgery/ultrasonography, Treatment Outcome, Young Adult
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Thyroid nodule volume decreased significantly, from 9.8 ¡¾ 8.5 ml before ablation to 0.9 ¡¾ 3.3 ml (P < 0.001) at final evaluation: a mean volume reduction of 93.4 ¡¾ 11.7 %. The mean cosmetic (P < 0.001) and symptom scores (P < 0.001) improved significantly.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.1007/s00330-012-2671-3.
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå